Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Corticosteroid Treatment on Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation

NCT01798420 is registered in ClinicalTrials.gov with The Nazareth Hospital, Israel as lead sponsor.

NCT NCT01798420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01798420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Corticosteroid Treatment on Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation
Lead sponsor
The Nazareth Hospital, Israel
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
October 31, 2012
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, diabetes